LYFAX | THISX | LYFAX / THISX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 5 years | 9 years | - |
Gain YTD | 2.394 | 4.441 | 54% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 500000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 53.1M | 13.4B | 0% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 5.64 | -6.91 | -82% |
Returns for 3 years | 7.82 | -6.70 | -117% |
Returns for 5 years | 26.89 | 2.70 | 995% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FIG | 21.40 | 0.39 | +1.87% |
Simplify Macro Strategy ETF | |||
BIB | 53.51 | 0.47 | +0.89% |
ProShares Ultra Nasdaq Biotechnology | |||
JVAL | 44.97 | -0.02 | -0.04% |
JPMorgan US Value Factor ETF | |||
EMBD | 22.73 | -0.02 | -0.09% |
Global X Emerging Markets Bond ETF | |||
SPMB | 21.55 | -0.04 | -0.19% |
SPDR® Portfolio Mortgage Backed Bond ETF |